Product details

GLP-T 60MG

GLP-T 60MG provides the highest single-vial dose of the dual incretin agonist analog, suited for researchers running long-duration studies, dose-escalation protocols, or comparative research across multiple subjects. The dual GLP-1/GIP mechanism — activating both incretin receptors simultaneously — continues to be a major focus of metabolic science, with research examining how this combined pathway affects insulin sensitivity, fat distribution, gastric motility, and hypothalamic appetite signaling compared to single-receptor approaches. At 60MG, this vial supports extended research without introducing batch variation from multiple reorders. For research and educational purposes only. Not intended for weight loss or the treatment of obesity.